| ctDNA-guided Treatment Decision-making (NCT07394218) | Fudan University | 2025-12-24 |
| Evaluating the Clinical Value of Transparent Cap-Assisted Second Examination of the Sigmoid Colon for Improving Colorectal Adenoma Detection Rates (NCT07261319) | Fudan University | 2025-12-15 |
| Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention (NCT07276763) | Fudan University | 2025-12-10 |
| AI-assisted Integrated Care to Promote Colonoscopy Uptake (NCT07261059) | Fudan University | 2025-12-08 |
| A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread (NCT07256223) | Fudan University | 2025-12-01 |
| DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC (NCT07207824) | Fudan University | 2025-12-01 |
| Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test (NCT06943768) | Fudan University | 2025-12-01 |
| Adjuvant Chemotherapy for BTC Based on 3D-PTA (NCT07296666) | Fudan University | 2025-12-01 |
| Lactiplantibacillus Plantarum PD01 Supplementation Reduces Microplastics and Microplastic-associated Chemicals in Humans (NCT07416214) | Fudan University | 2025-11-30 |
| Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study (NCT07270861) | Fudan University | 2025-11-15 |
| AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC) (NCT07544784) | Fudan University | 2025-11-04 |
| The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion Therapy (NCT07757165) | Fudan University | 2025-11-01 |
| Sacituzumab Tirumotecan in Combination With Furmonertinib as Second-line Treatment for EGFR-mutant Advanced or Metastatic NSCLC After Failure of First-line Third-generation EGFR-TKI Therapy (NCT07193160) | Fudan University | 2025-11-01 |
| T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis (NCT07152782) | Fudan University | 2025-11-01 |
| Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery (NCT07264556) | Fudan University | 2025-11-01 |
| Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases (NCT07469267) | Fudan University | 2025-10-24 |
| Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer (NCT07262671) | Fudan University | 2025-10-16 |
| The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors (NCT07159048) | Fudan University | 2025-10-15 |
| Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC (NCT07152769) | Fudan University | 2025-10-15 |
| Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET) (NCT07283575) | Fudan University | 2025-10-10 |
| Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker (NCT07120451) | Fudan University | 2025-10-10 |
| The Fever Clinic Acute Respiratory Cohort (NCT07278700) | Fudan University | 2025-10-10 |
| The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol (NCT07537205) | Fudan University | 2025-10-08 |
| CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer (NCT07213206) | Fudan University | 2025-10-07 |
| Development and Validation of an Artificial Intelligence-assisted System for Bowel Cleanliness Assessment Based on Withdrawal Distance Weighting (NCT07150130) | Fudan University | 2025-10-01 |
| A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma. (NCT07205185) | Fudan University | 2025-10-01 |
| Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC) (NCT07156604) | Fudan University | 2025-09-30 |
| SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd Treatment (NCT07182721) | Fudan University | 2025-09-30 |
| An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy (NCT07117630) | Fudan University | 2025-09-25 |
| Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer (NCT07117877) | Fudan University | 2025-09-15 |
| Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention (NCT07156591) | Fudan University | 2025-09-15 |
| Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study (NCT07179939) | Fudan University | 2025-09-10 |
| Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer (NCT07194005) | Fudan University | 2025-09-04 |
| Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy (NCT07164690) | Fudan University | 2025-09-01 |
| De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial (NCT07153757) | Fudan University | 2025-09-01 |
| Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC (NCT07303023) | Fudan University | 2025-09-01 |
| Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer (NCT07107035) | Fudan University | 2025-09-01 |
| T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis (NCT07150208) | Fudan University | 2025-09-01 |
| Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma. (NCT07147088) | Fudan University | 2025-09-01 |
| Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment (NCT07147101) | Fudan University | 2025-09-01 |
| Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma (NCT07389876) | Fudan University | 2025-09-01 |
| Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas (NCT07183280) | Fudan University | 2025-09-01 |
| Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules (NCT05871437) | Fudan University | 2025-09-01 |
| Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer (NCT07169916) | Fudan University | 2025-09-01 |
| The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment (NCT07395960) | Fudan University | 2025-09-01 |
| Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC) (NCT07150949) | Fudan University | 2025-08-28 |
| Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma (NCT07070700) | Fudan University | 2025-08-20 |
| TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment (NCT07100405) | Fudan University | 2025-08-15 |
| HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA) (NCT07105748) | Fudan University | 2025-08-15 |
| Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study (NCT07095699) | Fudan University | 2025-08-15 |
| Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab (NCT07100392) | Fudan University | 2025-08-14 |
| Zhongshan Ketogenic Diet Study 1 (NCT07117903) | Fudan University | 2025-08-10 |
| EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade (NCT07079436) | Fudan University | 2025-08-10 |
| Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer (NCT07154316) | Fudan University | 2025-08-01 |
| MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I) (NCT06879873) | Fudan University | 2025-08-01 |
| A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer (NCT05660213) | Fudan University | 2025-08-01 |
| Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer (NCT07025850) | Fudan University | 2025-08-01 |
| A Prognostic Model for COPD Complicated With Sarcopenic Obesity Based on Bioelectrical Impedance Phase Angle Technology (NCT07136246) | Fudan University | 2025-08-01 |
| MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II) (NCT06879886) | Fudan University | 2025-08-01 |
| Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer (NCT07034365) | Fudan University | 2025-08-01 |
| MRD-Guided Surveillance in Locally Advanced Mid-Low Rectal Cancer (SURVEILLANCE-III) (NCT06879899) | Fudan University | 2025-08-01 |
| Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study (NCT07132463) | Fudan University | 2025-08-01 |
| A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease (NCT07117851) | Fudan University | 2025-08-01 |
| Transparent Cap-Assisted Colonoscopy Combined With Computer-Aided Detection in Improving the Detection Rate of Colorectal Adenomas (NCT07097350) | Fudan University | 2025-08-01 |
| AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP） (NCT07082049) | Fudan University | 2025-07-27 |
| Incidence of 107 Lymph Node Metastasis (NCT07165184) | Fudan University | 2025-07-21 |
| Incidence of 106TBL Lymph Node Metastasis (NCT07165210) | Fudan University | 2025-07-21 |
| A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS) (NCT06992882) | Fudan University | 2025-07-08 |
| Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab (NCT07047586) | Fudan University | 2025-07-02 |
| Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis (NCT06943807) | Fudan University | 2025-07-01 |
| An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori (NCT06896370) | Fudan University | 2025-07-01 |
| Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients (NCT06999252) | Fudan University | 2025-07-01 |
| Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection (NCT06943781) | Fudan University | 2025-07-01 |
| Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer (NCT06973421) | Fudan University | 2025-07-01 |
| Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer (NCT07041437) | Fudan University | 2025-06-30 |
| Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients (NCT07021261) | Fudan University | 2025-06-16 |
| CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS) (NCT07019363) | Fudan University | 2025-06-15 |
| Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer (NCT07005557) | Fudan University | 2025-06-15 |
| A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer (NCT07653893) | Fudan University | 2025-06-11 |
| Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor (NCT06996093) | Fudan University | 2025-06-02 |
| Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer (NCT06925126) | Fudan University | 2025-06-01 |
| HPV Genotype Attribution and Disease Burden of Anal Cancer in China (NCT06670495) | Fudan University | 2025-06-01 |
| TACE Plus Ivonescimab for Unresectable Non-Metastatic HCC (NCT06990620) | Fudan University | 2025-06-01 |
| UEMR Versus HSP in the Treatment of Pedunculated Colorectal Polyps Less Than 10mm in Size (NCT06996522) | Fudan University | 2025-06-01 |
| Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer (NCT06956976) | Fudan University | 2025-06-01 |
| The Effect of Cap-assisted Water Exchange Colonoscopy on Straight Passage of the Colonoscope Through the Sigmoid Colon, Without Loop Formation (NCT06992856) | Fudan University | 2025-06-01 |
| Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer (NCT06977542) | Fudan University | 2025-06-01 |
| Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage (NCT06965556) | Fudan University | 2025-06-01 |
| Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC (NCT07705438) | Fudan University | 2025-05-28 |
| Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer (NCT06970353) | Fudan University | 2025-05-27 |
| A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL (NCT06966154) | Fudan University | 2025-05-26 |
| GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1） (NCT06988592) | Fudan University | 2025-05-23 |
| A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma (NCT07105592) | Fudan University | 2025-05-13 |
| Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET (NCT07070648) | Fudan University | 2025-05-09 |
| Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation (NCT07001540) | Fudan University | 2025-05-08 |
| Active Surveillance for Limited GGNs (NCT06394037) | Fudan University | 2025-05-01 |
| Understanding the Public Impact on Dengue Vaccination Strategies in Yunnan Province, China: A Dynamic Transmission Modeling Study (NCT07206784) | Fudan University | 2025-05-01 |
| Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06) (NCT06919848) | Fudan University | 2025-05-01 |
| Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma (NCT06957938) | Fudan University | 2025-04-28 |
| Ozone Reaction Products and Skin Health (NCT06932419) | Fudan University | 2025-04-28 |